Literature DB >> 12424674

[Ultrasound-guided puncture of the subclavian vein to implant central venous ports].

R Adamus1, S Beyer-Enke, P Otte, R Loose.   

Abstract

PURPOSE: To assess the safety and efficacy of ultrasound guided puncture of the subclavian vein instead of blind puncture or surgical procedure. The advantages compared with implantation of brachial ports are demonstrated. PATIENTS AND METHODS: In 41 oncologic patients the subclavian vein was punctured by ultrasound guidance in order to implant a port (34 left side, 7 right side). The study included 21 women and 20 men (range 34 - 79, mean 61 years). Imaging of the subclavian vein was performed with a 7,5 MHz linear ultrasound probe in B-mode and in colour doppler mode. Puncture was performed under ultrasound control (18 G, 45 mm needle when skin-vessel distance was < 3 cm, 19 G, 75 mm needle when skin-vessel distance was > 3 cm). In 27 patients a Bardport was implanted, in 14 patients a Vitalport (Cook). In three patients surgical port implantation failed. One of these patients had a partial thrombosis of the subclavian vein.
RESULTS: Technical success was 100 %. In one patient we first punctured the subclavian artery at the beginning of our series without any complication. All port systems could be implanted. There was one haematoma in the port pocket without any effect to the port function. In the three surgical patients subclavian vein puncture and portimplantation was successful.
CONCLUSION: Ultrasound guided puncture of the subclavian vein and port implantation by radiologists is a save procedure. A low risk approach to the subclavian vein is possible at any location. The long approach through the cubital vein with brachial port implantation is not necessary.

Entities:  

Mesh:

Year:  2002        PMID: 12424674     DOI: 10.1055/s-2002-35352

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.

Authors:  Ulf K M Teichgräber; Stephan Kausche; Sebastian N Nagel; Bernhard Gebauer
Journal:  Eur Radiol       Date:  2011-01-05       Impact factor: 5.315

2.  Applicability of TIVAP versus PICC in non-hematological malignancies patients: A meta-analysis and systematic review.

Authors:  Baiying Liu; Zhiwei Wu; Changwei Lin; Liang Li; Xuechun Kuang
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.